|Scientists, engineers and clinicians at the forefront of research on nanotechnology and its applications for cancer detection and treatment will participate in the second annual two-day "Frontiers of Nanotechnology Symposium" this week at Callaway Gardens in Pine Mountain, Georgia.
The April 2-3 symposium is sponsored by the Emory-Georgia Tech Center of Cancer Nanotechnology Excellence, the Bioengineering Research Partnership, the Georgia Cancer Coalition and the Georgia Research Alliance.
Speakers from around the country will address innovative research being conducted in the field of cancer nanotechnology, including cancer proteomics, molecular imaging, molecular profiling, individualized therapy and biocomputing.
Keynote speakers include Wadih Arap, MD, PhD, University of Texas M.D. Anderson Cancer Center; Don Giddens, PhD, Georgia Institute of Technology; Charles L. Sawyers, MD, Memorial Sloan-Kettering Cancer Center, New York; Jan Schnitzer, MD, Sidney Kimmel Cancer Center, San Diego; and Chih-Ming Ho, PhD, University of California, Los Angeles.
Distinguished speakers from Emory and Georgia Tech will describe progress in their own research laboratories, including development of "quantum dot" semiconductor nanoparticles and other nanotechnologies with promise for diagnosis and treatment.
In 2005 the National Cancer Institute of the National Institutes of Health selected Emory and Georgia Tech as one of seven National Centers of Cancer Nanotechnology Excellence and awarded the center a grant of approximately $19 million over five years. Emory and Georgia Tech possess one of the largest federally funded programs in the U.S. for biomedical nanotechnology.
For registration and additional information about the symposium, please contact Michelle Denney at 404-727-0391 or email@example.com.